title: Dynamics and control of a mathematical model for metronomic chemotherapy.
abstract: A 3-compartment model for metronomic chemotherapy that takes into account cancerous cells, the tumor vasculature and tumor immune-system interactions is considered as an optimal control problem. Metronomic chemo-therapy is the regular, almost continuous administration of chemotherapeutic agents at low dose, possibly with small interruptions to increase the efficacy of the drugs. There exists medical evidence that such administrations of specific cytotoxic agents (e.g., cyclophosphamide) have both antiangiogenic and immune stimulatory effects. A mathematical model for angiogenic signaling formulated by Hahnfeldt et al. is combined with the classical equations for tumor immune system interactions by Stepanova to form a minimally parameterized model to capture these effects of low dose chemotherapy. The model exhibits bistable behavior with the existence of both benign and malignant locally asymptotically stable equilibrium points. In this paper, the transfer of states from the malignant into the benign regions is used as a motivation for the construction of an objective functional that induces this process and the analysis of the corresponding optimal control problem is initiated.
authors.affiliation: Dept. of Mathematics and Statistics, Southern Illinois University, Edwardsville, Il 62025, United States email: uledzew@siue.edu.
authors.forename: Urszula
authors.initials: U
authors.lastname: Ledzewicz
authors.forename: Behrooz
authors.initials: B
authors.lastname: Amini
authors.forename: Heinz
authors.initials: H
authors.lastname: Schättler
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D059250:Administration, Metronomic; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D055641:Mathematical Concepts; D008954:Models, Biological; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents